Article Details
Retrieved on: 2018-03-18 18:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>TwoXar, a biopharmaceutical startup that uses artificial intelligence (AI) to identify and develop new medicines, has raised $10 million in a series A round of funding led by SoftBank's early-stage venture capital firm SoftBank Ventures, with participation from <b>Andreessen Horowitz</b> and Braintree founder ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here